Search IDVs

36E79726D0035

Indefinite Delivery Contract

Overview

Government Description
New award for venlafaxine hydrochloride (HCL) 24HR Sustained Action (SA) capsules with puracap laboratories, llc dba blu pharmaceuticals. Period of performance is aug. 30, 2026 to aug. 29, 2026 with four one-year options.
Awardee
Puracap Laboratories
Awarding / Funding Agency
National Acquisition Center (NAC) [VA - HQ]
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Multiple Agencies
Vehicle Ceiling
$32,351,492 (0% Used)
Related Opportunity
Venlafaxine 24HR Sustained Action Capsules (36E79726R0010)
Puracap Laboratories was awarded Indefinite Delivery Contract 36E79726D0035 (36E797-26-D-0035) by National Acquisition Center in August 2026. The IDC was awarded through solicitation Venlafaxine 24HR Sustained Action Capsules full & open with NAICS 325412 and PSC 6505 via direct negotiation acquisition procedures with 7 bids received. The total ceiling is $32,351,492, of which 0% has been used.

Status
(Open)

Modified 6/24/26
Period of Performance
8/29/26
Start Date
8/29/27
Ordering Period End Date
0% Complete

Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
0% Funded

Award Hierarchy

Indefinite Delivery Contract

36E79726D0035

Contracts

0

Subcontracts

0

Opportunity Lifecycle

Procurement history for 36E79726D0035

Transaction History

Modifications to 36E79726D0035

People

Suggested agency contacts for 36E79726D0035

Competition

Number of Bidders
7
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
CMJ7J1HLH9N4
Awardee CAGE
4JB85
Agency Detail
Awarding Office
36E797 NAC PHARMACEUTICALS (36E797)
Funding Office
36E797 NAC PHARMACEUTICALS (36E797)
Created By
andrew.cazares@va.gov
Last Modified By
nicholas.mcgregor@va.gov
Approved By
nicholas.mcgregor@va.gov

Legislative

Legislative Mandates
None Applicable
Awardee District
NY-03
Senators
Kirsten Gillibrand
Charles Schumer
Representative
George Santos
Last Modified: 6/24/26